Fig. 5

Thermogravimetric and differential scanning calorimetry (TG-DSC) curve of the in-situ gel formulations compared to pure drugs and polymer (a) Rifampicin, (b) Isoniazid, (c) Poloxamer, (d) ISGRIF2, (e) ISGINZF3, (f) ISGRIFINZ4, (g) ISGRIF6, (h) ISGINZF7, and (i) ISGRIFINZ8.